Skip to content
10-K

Annual Report

Apogee Therapeutics, Inc. APGE

0001974640-26-000002

← back to feed
Filed
Mar 2, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 60.69M sh
Shares Diluted FY 2025 · Dec 31, 2024 55.19M sh
Shares Diluted FY 2025 · Dec 31, 2023 25.01M sh
Shares Outstanding FY 2025 · Dec 31, 2025 68.4M sh
Shares Outstanding FY 2025 · Dec 31, 2024 58.06M sh
Capex FY 2025 · Dec 31, 2025 $5.15M
Capex FY 2025 · Dec 31, 2024 $1.15M
Capex FY 2025 · Dec 31, 2023 $167K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$227.45M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$171.17M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$74.76M
Cash And Equivalents FY 2025 · Dec 31, 2025 $131.55M
Cash And Equivalents FY 2025 · Dec 31, 2024 $141.79M
Cash And Equivalents FY 2025 · Dec 31, 2023 $118.32M
Current Liabilities FY 2025 · Dec 31, 2025 $27.91M
Current Liabilities FY 2025 · Dec 31, 2024 $28.56M
Total Liabilities FY 2025 · Dec 31, 2025 $33.25M
Total Liabilities FY 2025 · Dec 31, 2024 $37.16M
Current Assets FY 2025 · Dec 31, 2025 $741.36M
Current Assets FY 2025 · Dec 31, 2024 $529.71M
Total Assets FY 2025 · Dec 31, 2025 $937.13M
Total Assets FY 2025 · Dec 31, 2024 $753.95M
Eps Diluted FY 2025 · Dec 31, 2025 −$4.22
Eps Diluted FY 2025 · Dec 31, 2024 −$3.30
Eps Diluted FY 2025 · Dec 31, 2023 −$3.36
Eps Basic FY 2025 · Dec 31, 2025 −$4.22
Eps Basic FY 2025 · Dec 31, 2024 −$3.30
Eps Basic FY 2025 · Dec 31, 2023 −$3.36
Sga Expense FY 2025 · Dec 31, 2025 $70.88M
Sga Expense FY 2025 · Dec 31, 2024 $49.01M
Sga Expense FY 2025 · Dec 31, 2023 $24.58M
Rd Expense FY 2025 · Dec 31, 2025 $214.71M
Rd Expense FY 2025 · Dec 31, 2024 $167.87M
Rd Expense FY 2025 · Dec 31, 2023 $68.42M
Net Income FY 2025 · Dec 31, 2025 −$255.84M
Net Income FY 2025 · Dec 31, 2024 −$182.15M
Net Income FY 2025 · Dec 31, 2023 −$83.99M
Operating Income FY 2025 · Dec 31, 2025 −$285.6M
Operating Income FY 2025 · Dec 31, 2024 −$216.87M
Operating Income FY 2025 · Dec 31, 2023 −$93M